Search clinical trials for: Placebo for PF-06817024
Total 2812 results
-
PfizerCompletedHealthy VolunteersUnited States, Belgium
-
PfizerYale UniversityCompleted
-
PfizerCompletedObesityUnited States, Taiwan, Canada, Japan
-
PfizerPfizerRecruitingSickle Cell DiseaseUnited States, Nigeria, Kenya, Lebanon
-
PfizerCompletedDiabetes Mellitus, Type 2 | NIDDMUnited States
-
PfizerCompleted
-
PfizerCompletedDermatomyositisUnited States, Spain, Poland, Germany, Hungary
-
PfizerCompleted
-
Cerevel Therapeutics, LLCRecruitingHealthy Participants | Alzheimer's Disease DementiaUnited States
-
PfizerCompletedDiabetic NephropathiesUnited States, Korea, Republic of, Sweden, Canada, Hong Kong, Serbia, Denmark, Australia, Malaysia, Slovakia, South Africa, India, United Kingdom, Poland, Mexico
-
PfizerBristol-Myers SquibbCompletedHealthy | Obesity | OverweightUnited States
-
PfizerCompletedAlzheimer's DiseaseCanada, United Kingdom, Australia, Sweden
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
PfizerCompleted
-
PfizerCompletedAcne InversaUnited States, Australia, Canada
-
PfizerCompletedAlzheimer's DiseaseSweden
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
Yale UniversityNational Institute of Mental Health (NIMH); University of Pennsylvania; Columbia... and other collaboratorsActive, not recruitingEarly Course Schizophrenia Spectrum DisorderUnited States
-
Icahn School of Medicine at Mount SinaiPfizerRecruitingSeborrheic Dermatitis | Papulopustular RosaceaUnited States
-
PfizerCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited States
-
PfizerTerminated
-
PfizerCompleted
-
PfizerTerminatedDiabetes Mellitus, Type 2United States
-
PfizerTerminatedHepatitis C, ChronicTaiwan, Singapore, India, Korea, Republic of, Hong Kong
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
PfizerCompleted
-
Columbia UniversityPfizerWithdrawnNASH (Nonalcoholic Steatohepatitis) | NAFLD (Nonalcoholic Fatty Liver Disease)
-
PfizerCompletedInfluenza, HumanUnited States
-
PfizerCompletedSystemic Lupus ErythematosusSpain, United States, Taiwan, Belgium, Czechia, Japan, Hungary, Germany, United Kingdom, China, France, Australia, Bulgaria, Hong Kong, Korea, Republic of, Colombia, Argentina, Canada, Greece, Italy, Mexico, Poland, Portugal, Romania, S... and more
-
PfizerTerminatedParkinson DiseaseUnited States, Spain, Canada, France, Japan, Germany
-
PfizerCompleted
-
Karolinska University HospitalCompleted
-
PfizerCompleted
-
PfizerCompletedHealthy ParticipantsUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMigraine | Major Depressive DisorderUnited States, Czechia, Finland, Israel, Italy, Russian Federation, Spain, Ukraine, France, Germany, Greece, Poland, United Kingdom
-
PfizerCompletedInherited ErythromelalgiaUnited States
-
PfizerCompleted
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
PfizerTerminated
-
PfizerTerminatedAlzheimer's DiseaseUnited States
-
PfizerCompletedType 2 Diabetes PatientsUnited States
-
PfizerCompletedAlzheimer's DiseaseUnited States, Sweden
-
PfizerCompletedRespiratory Tract InfectionsUnited States
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerCompletedDiabetes Mellitus, Type 2Canada, United States, Korea, Republic of, Puerto Rico
-
PfizerCompletedHypercholesterolemiaUnited States
-
Telavant, Inc.PfizerCompleted